Dasagrandhi Divya, Muthuswamy Anusuyadevi, Swaminathan Jayachandran Kesavan
Drug Discovery and Molecular Cardiology Laboratory, Department of Bioinformatics, Bharathidasan University, Tiruchirappalli, 620024, India.
Molecular Neurogerontology Laboratory, Department of Biochemistry, Bharathidasan University, Tiruchirappalli, 620024, India.
Mol Cell Biochem. 2022 Feb;477(2):571-584. doi: 10.1007/s11010-021-04307-x. Epub 2021 Nov 29.
Cardiovascular diseases (CVDs) are the foremost cause of mortality worldwide. Atherosclerosis is the underlying pathology behind CVDs. Atherosclerosis is manifested predominantly by lipid deposition, plaque formation, and inflammation in vascular intima. Initiation and progression of plaque require many years. With aging, atherosclerotic plaques become vulnerable. Localization of these plaques in the coronary artery leads to myocardial infarction. A complete understanding of the pathophysiology of this multifaceted disease is necessary to achieve the clinical goal to provide early diagnosis and the best therapeutics. The triggering factors of atherosclerosis are biomechanical forces, hyperlipidemia, and chronic inflammatory response. The current review focuses on crucial determinants involved in the disease, such as location, hemodynamic factors, oxidation of low-density lipoproteins, and the role of endothelial cells, vascular smooth muscle cells, and immune cells, and better therapeutic targets.
心血管疾病(CVDs)是全球首要的死亡原因。动脉粥样硬化是心血管疾病背后的潜在病理机制。动脉粥样硬化主要表现为脂质沉积、斑块形成以及血管内膜炎症。斑块的起始和进展需要多年时间。随着年龄增长,动脉粥样硬化斑块变得不稳定。这些斑块在冠状动脉中的定位会导致心肌梗死。要实现提供早期诊断和最佳治疗方法的临床目标,全面了解这种多方面疾病的病理生理学是必要的。动脉粥样硬化的触发因素是生物力学力、高脂血症和慢性炎症反应。本综述聚焦于该疾病涉及的关键决定因素,如位置、血流动力学因素、低密度脂蛋白氧化以及内皮细胞、血管平滑肌细胞和免疫细胞的作用,以及更好的治疗靶点。